Core Laboratories NV logo

CLB - Core Laboratories NV News Story

$42.17 -0.7  -1.7%

Last Trade - 9:00pm

Mid Cap
Market Cap £1.46bn
Enterprise Value £1.59bn
Revenue £318.2m
Position in Universe 2271st / 6938

Core Laboratories NV reports results for the quarter ended in March - Earnings Summary

Wed 21st April, 2021 11:45pm
* Core Laboratories NV  CLB.N  reported quarterly adjusted
earnings of 15 cents​​ per share for the quarter ended in March.
The mean expectation of twelve analysts for the quarter was
for earnings of 13 cents per share.
* Revenue fell 28.9% to $108.38 million from a year ago​; 
analysts expected $110.70 million.
* Core Laboratories NV's reported EPS for the quarter was 18
* The mean earnings estimate of analysts had fallen by about 21%
in the last three months.​ 
* In the last 30 days five analysts negatively revised earnings
* Core Laboratories NV shares had fallen by 9.0% this
quarter and lost 1.2% so far this year.
* The company reported quarterly net income of $8.11 million.
* Wall Street's median 12-month price target for Core
Laboratories NV is $31.50 
* The current average analyst rating on the shares is "hold" and
the breakdown of recommendations is 4 "strong buy" or "buy," 8
"hold" and 1 "sell" or "strong sell." 
This summary was machine generated April 21 at 10:45 p.m. GMT.
​All figures in US Dollars.​
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.